# FDA 483 - Deerland Enzymes dba Deerland Probiotics and Enzymes Inc. - December 19, 2024

Source: https://www.globalkeysolutions.net/records/483/deerland-enzymes-dba-deerland-probiotics-and-enzymes-inc/2c1e8bea-12b2-4032-993e-43da3a25ad5a

> FDA 483 for Deerland Enzymes dba Deerland Probiotics and Enzymes Inc. on December 19, 2024. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Deerland Enzymes dba Deerland Probiotics and Enzymes Inc.
- Inspection Date: 2024-12-19
- Product Type: drugs
- Office Name: Atlanta District Office
- Summary: Deerland Enzymes dba Deerland Probiotics and Enzymes Inc. in Kennesaw, GA, a dietary supplement contract manufacturer, received a Form 483 with five observations. The inspection revealed significant issues with master manufacturing records, including a lack of specifications for ingredients, endotoxin testing, and pesticide testing for incoming materials. Additionally, the firm failed to verify the identity of a dietary ingredient, used unsuitable equipment, and had deficiencies in quality control review of monitoring records.

## Related Officers

- [Consumer Safety Officer](https://www.globalkeysolutions.net/people/sandra-i-gaul/8eb0f040-66a5-4d82-8327-5cf984931609)

Company: https://www.globalkeysolutions.net/companies/deerland-enzymes-dba-deerland-probiotics-and-enzymes-inc/c1a1d943-4a38-4359-a957-4c961d5c5e7c

Office: https://www.globalkeysolutions.net/offices/atlanta-district-office/7586d99a-288e-49d1-8c3d-d88b7354b7a7